Total Payments
$10,311
2024 Payments
$961.29
Companies
49
Transactions
544
Medicare Patients
988
Medicare Billing
$124,438
Payment Breakdown by Category
Food & Beverage$10,290 (99.8%)
Education$20.64 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,290 | 540 | 99.8% |
| Education | $20.64 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,462 | 83 | $0 (2024) |
| ABBVIE INC. | $914.51 | 61 | $0 (2024) |
| Lilly USA, LLC | $749.08 | 35 | $0 (2024) |
| Novo Nordisk Inc | $707.52 | 57 | $0 (2023) |
| Corcept Therapeutics | $694.10 | 27 | $0 (2024) |
| Abbott Laboratories | $668.42 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $639.56 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $614.12 | 33 | $0 (2023) |
| Allergan, Inc. | $456.26 | 32 | $0 (2021) |
| Amgen Inc. | $432.45 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $961.29 | 33 | GlaxoSmithKline, LLC. ($203.49) |
| 2023 | $981.59 | 41 | Novo Nordisk Inc ($166.45) |
| 2022 | $1,314 | 55 | Abbott Laboratories ($227.63) |
| 2021 | $1,756 | 89 | AbbVie Inc. ($369.92) |
| 2020 | $1,354 | 75 | Allergan, Inc. ($237.09) |
| 2019 | $1,021 | 54 | AstraZeneca Pharmaceuticals LP ($199.29) |
| 2018 | $1,256 | 86 | Novo Nordisk Inc ($230.66) |
| 2017 | $1,666 | 111 | AstraZeneca Pharmaceuticals LP ($275.12) |
All Payment Transactions
544 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $140.63 | General |
| Category: Diabetes Care | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: PAIN | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $72.92 | General |
| Category: Analgesic | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $32.47 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Analgesic | ||||||
| 05/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 260 | 465 | $59,487 | $36,814 |
| 2022 | 3 | 153 | 232 | $31,185 | $19,023 |
| 2021 | 5 | 277 | 490 | $59,605 | $37,947 |
| 2020 | 6 | 298 | 583 | $51,072 | $30,655 |
Total Patients
988
Total Services
1,770
Medicare Billing
$124,438
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 279 | $41,792 | $25,461 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 89 | $9,345 | $6,082 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $3,700 | $2,799 | 75.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,065 | $1,021 | 49.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 20 | $1,300 | $828.56 | 63.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 31 | $935.00 | $352.20 | 37.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $350.00 | $270.34 | 77.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 175 | $26,250 | $16,184 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 43 | $4,515 | $2,682 | 59.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 14 | $420.00 | $156.78 | 37.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 137 | 316 | $47,305 | $30,602 | 64.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 68 | $7,015 | $3,955 | 56.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $2,850 | $1,840 | 64.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 59 | 59 | $1,475 | $1,166 | 79.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 32 | $960.00 | $382.72 | 39.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 140 | 318 | $39,767 | $23,615 | 59.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 89 | $7,565 | $5,087 | 67.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 40 | 40 | $1,000 | $756.80 | 75.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 28 | 60 | $1,800 | $617.43 | 34.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 16 | $880.00 | $535.03 | 60.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 14 | 60 | $60.00 | $43.76 | 72.9% |
About Dr. Ruby Sia, MD
Dr. Ruby Sia, MD is a Internal Medicine healthcare provider based in Apple Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518061860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruby Sia, MD has received a total of $10,311 in payments from pharmaceutical and medical device companies, with $961.29 received in 2024. These payments were reported across 544 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,290).
As a Medicare-enrolled provider, Sia has provided services to 988 Medicare beneficiaries, totaling 1,770 services with total Medicare billing of $124,438. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Apple Valley, CA
- Active Since 09/08/2006
- Last Updated 10/12/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518061860
Products in Payments
- FARXIGA (Drug) $921.93
- Korlym (Drug) $694.10
- UBRELVY (Drug) $545.55
- VRAYLAR (Drug) $447.29
- TOUJEO (Drug) $425.71
- Victoza (Drug) $394.70
- XARELTO (Drug) $314.70
- MOUNJARO (Drug) $288.62
- FreeStyle Libre 2 (Device) $284.32
- ENTRESTO (Drug) $283.41
- NURTEC ODT (Drug) $272.30
- TRULICITY (Drug) $225.30
- JARDIANCE (Drug) $218.87
- BREO (Drug) $197.57
- EVENITY (Biological) $188.52
- ELIQUIS (Drug) $181.21
- TRELEGY ELLIPTA (Drug) $168.48
- FREESTYLE LIBRE 3 (Device) $156.47
- Aimovig (Biological) $151.31
- AREXVY (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Apple Valley
Dr. Alden Jallorina, M.d, M.D
Internal Medicine — Payments: $10,582
Internal Medicine $10,582
Ricardo Gomez, M.d, M.D
Internal Medicine — Payments: $10,411
Internal Medicine $10,411
Bhairavi Patel, Md, MD
Internal Medicine — Payments: $6,161
Internal Medicine $6,161
Mr. Mark Lauron, M.d, M.D
Internal Medicine — Payments: $5,491
Internal Medicine $5,491
Radha Menon, M.d, M.D
Internal Medicine — Payments: $4,489
Internal Medicine $4,489
Dr. Robert Boldy, M.d, M.D
Internal Medicine — Payments: $4,347
Internal Medicine $4,347